Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
46
ANTX Quote, Financials, Valuation and Earnings
Last price:
$1.44
Seasonality move
:
-47.68%
Day range:
$1.34 - $1.41
52-week range:
$0.87 - $22.22
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.47x
Volume:
88.7K
Avg. volume:
796.2K
1-year change:
-93.38%
Market cap:
$41.2M
Revenue:
--
EPS (TTM):
-$2.04
Earnings Data
Next earnings date for ANTX
Mar 28
2025
Most recent earnings per share
-$0.43
Missed by $0.04
(Nov 13/2024)
Consensus Estimate
-$0.39
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ANTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/28/2025 | Q4 | -- | -- | -- | -$0.26 | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.43 | -$0.39 | -$0.04 |
| 08/13/2024 | Q2 | -- | -- | -$0.48 | -$0.59 | $0.11 |
| 05/14/2024 | Q1 | -- | -- | -$0.56 | -$0.62 | $0.06 |
| 03/28/2024 | Q4 | -- | -- | -$0.57 | -$0.75 | $0.18 |
| 11/09/2023 | Q3 | -- | -- | -$0.65 | -$0.63 | -$0.02 |
| 08/10/2023 | Q2 | -- | -- | -$0.81 | -$0.85 | $0.04 |
| 05/11/2023 | Q1 | -- | -- | -$0.79 | -$0.68 | -$0.11 |
| 03/29/2023 | Q4 | -- | -- | -$0.61 | -$0.65 | $0.04 |
| 11/09/2022 | Q3 | -- | -- | -$0.59 | -$0.60 | $0.01 |
| 08/11/2022 | Q2 | -- | -- | -$0.52 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$2.98 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.52 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.63 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.49 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.20 | -- | -- |
AN2 Therapeutics Earnings Questions
-
How Much did AN2 Therapeutics Generate in Revenue Last Quarter?
AN2 Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did AN2 Therapeutics Beat Earnings Last Quarter?
AN2 Therapeutics announced earnings per share of -$0.43 which represents a miss of analyst forecast a -$0.39 per share.
-
Is AN2 Therapeutics Profitable?
AN2 Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for AN2 Therapeutics EPS Next Year?
AN2 Therapeutics's earnings are forecast to decrease from -$2.74 per share to -$2.94 per share next year representing a decrease of -47.08%.
-
When is AN2 Therapeutics's Earnings Date?
AN2 Therapeutics's next earnings date is March 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
